StockData
Legend Biotech Corp logo

Legend Biotech Corp (LEGN) stock

LEGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 10, 2026Score 3/30
$16.25+0.14 (+0.87%)

Close on Nov 18, 2026Market cap $3.01BP/E –Yield –

Legend Biotech price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Legend Biotech's price to book ratio was 7.0× on Jul 31, 2025, against 8.7× a year earlier. Over the last 5 years it ranged from 4.5× to 22.5×, with a median of 8.2×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Jul 31, 20257.0×+1.7
2024Dec 31, 20245.3×−2.4
2023Dec 29, 20237.7×−1.5
2022Dec 30, 20229.2×−7.0
2021Dec 31, 202116.2×−2.4
2020Dec 31, 202018.6×–

More Legend Biotech figures

See a number that looks wrong?